Tag: virus-like particle (VLP)

Allergy Therapeutics

Company Announces First Patient Dosing with Peanut Allergy Vaccine

PROTECT Trial is evaluating the safety and tolerability of VLP Peanut.
Peanut Allergy Vaccine

FDA Clears Path for Human Clinical Trials of Peanut Allergy Vaccine

"Virus Like Particle" based vaccine promises short-course treatment providing long-term protection.
Peanut Allergy Vaccine

Peanut Allergy Vaccine Takes Another Step with Biomarker Study

Study will help establish the starting dose of its vaccine candidate for a subsequent in-human phase I study.
Peanut Allergy Vaccine

Allergy Therapeutics Publishes Encouraging New Data for Peanut Allergy Vaccine Candidate

"This study indicates a paradigm shift by addressing peanut allergy via a vaccination concept instead of classic desensitisation..."